Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 12 04:00PM ET
6.96
Dollar change
-0.26
Percentage change
-3.60
%
IndexRUT P/E- EPS (ttm)-0.84 Insider Own41.05% Shs Outstand43.91M Perf Week-6.45%
Market Cap444.05M Forward P/E- EPS next Y-1.90 Insider Trans19.63% Shs Float37.61M Perf Month-25.16%
Income-36.95M PEG- EPS next Q-0.24 Inst Own39.02% Short Float8.49% Perf Quarter50.98%
Sales0.00M P/S- EPS this Y-49.35% Inst Trans72.24% Short Ratio5.16 Perf Half Y112.84%
Book/sh1.86 P/B3.74 EPS next Y-51.69% ROA-33.24% Short Interest3.19M Perf Year53.64%
Cash/sh1.36 P/C5.12 EPS next 5Y- ROE-38.36% 52W Range2.18 - 13.68 Perf YTD52.97%
Dividend Est.- P/FCF- EPS past 5Y48.33% ROI-42.75% 52W High-49.12% Beta0.95
Dividend TTM- Quick Ratio9.49 Sales past 5Y0.00% Gross Margin- 52W Low219.27% ATR (14)0.65
Dividend Ex-Date- Current Ratio9.49 EPS Y/Y TTM45.68% Oper. Margin0.00% RSI (14)37.51 Volatility6.13% 7.49%
Employees42 Debt/Eq0.07 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price22.40
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q-37.82% Payout- Rel Volume0.36 Prev Close7.22
Sales Surprise- EPS Surprise-20.82% Sales Q/Q- EarningsMar 14 AMC Avg Volume618.84K Price6.96
SMA20-10.03% SMA50-22.28% SMA20038.60% Trades Volume219,897 Change-3.60%
Date Action Analyst Rating Change Price Target Change
Apr-03-24Initiated Leerink Partners Outperform $25
Nov-17-23Upgrade Citigroup Neutral → Buy $4.50
Oct-19-22Initiated Guggenheim Buy $12
Feb-15-22Downgrade William Blair Outperform → Mkt Perform
Feb-10-21Initiated JMP Securities Mkt Outperform
Feb-01-21Initiated William Blair Outperform $29
Mar-20-24 01:32PM
Mar-14-24 09:53PM
05:32PM
04:05PM
Mar-11-24 04:05PM
04:05PM Loading…
Mar-06-24 04:05PM
Feb-20-24 01:47PM
Feb-19-24 01:48PM
Feb-16-24 04:20PM
Feb-14-24 06:15AM
Feb-13-24 04:18PM
Feb-12-24 07:00AM
Nov-14-23 07:00AM
Nov-01-23 04:05PM
Oct-03-23 04:05PM
04:05PM Loading…
Aug-31-23 04:05PM
Aug-10-23 07:00AM
Aug-07-23 09:22AM
Jul-25-23 09:59AM
07:00AM
Jul-17-23 04:05PM
Jun-21-23 04:05PM
May-15-23 07:00AM
Mar-28-23 04:05PM
Mar-14-23 07:00AM
Feb-07-23 04:05PM
Nov-21-22 04:05PM
Nov-10-22 07:00AM
Nov-07-22 04:05PM
Oct-20-22 08:00AM
04:05PM Loading…
Oct-19-22 04:05PM
Sep-16-22 01:00PM
Sep-14-22 07:04AM
07:01AM
Aug-11-22 04:05PM
Jul-28-22 04:05PM
Jun-28-22 08:00AM
06:05AM
Jun-02-22 08:00AM
May-19-22 08:00AM
May-12-22 07:00AM
Apr-29-22 06:27AM
Apr-13-22 10:40AM
Mar-25-22 07:00AM
Feb-16-22 11:57AM
Feb-14-22 04:01PM
Jan-19-22 06:53AM
Nov-22-21 07:00AM
Nov-20-21 08:40AM
Nov-15-21 07:00AM
Nov-12-21 07:00AM
Sep-16-21 08:00AM
Sep-02-21 04:01PM
Aug-22-21 10:12AM
Aug-19-21 07:00AM
Aug-12-21 07:00AM
Aug-09-21 08:48AM
Jul-23-21 12:00PM
Jul-08-21 04:01PM
Jun-11-21 07:00AM
Jun-05-21 07:55PM
Jun-02-21 10:56PM
Jun-01-21 04:55AM
May-29-21 10:59PM
May-25-21 05:41PM
May-21-21 09:18AM
May-20-21 04:31PM
May-11-21 07:00AM
May-10-21 04:05PM
Mar-04-21 07:00AM
Mar-01-21 03:54AM
Feb-18-21 04:01PM
Dec-16-20 07:23PM
Dec-15-20 08:00AM
Dec-08-20 07:30AM
Nov-13-20 08:00AM
Nov-10-20 08:00AM
Oct-14-20 10:18PM
Oct-13-20 08:00AM
Sep-21-20 09:58AM
Sep-10-20 08:00AM
Sep-01-20 12:47PM
Aug-11-20 07:00AM
Aug-04-20 08:00AM
Jul-28-20 08:00AM
Jul-20-20 04:15PM
May-29-20 04:05PM
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Flynn James EDirectorFeb 16 '24Buy8.744,290,61737,499,9936,151,406Feb 16 02:37 PM
THOMAS FRANK EDirectorFeb 14 '24Buy11.002,00022,0002,000Feb 15 04:21 PM
Shankar GopiChief Development OfficerDec 07 '23Buy3.735,00018,6625,000Dec 08 04:08 PM
Celano MichaelChief Financial OfficerMay 17 '23Buy3.735,00018,632112,746May 18 02:13 PM
BEN-MAIMON CAROLEPresident and CEOMay 17 '23Buy3.715,00018,525266,829May 18 02:13 PM
Truitt JosephDirectorMay 17 '23Buy3.732,75010,2582,750May 18 02:12 PM